Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 17,626–17,650 of 27,380 studies, newest first · page 706 of 1096.

September 2014 25

  1. 2014-09-16

    Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

    ✓ Peer-reviewed Inflammation and the immune system Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Alzheimer's disease (AD) and Parkinson's disease (PD) are the two common neurodegenerative diseases characterized by progressive neuronal dysfunction in the presence of pathological microglial activation. +3 more findings

  2. 2014-09-16

    Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis

    ✓ Peer-reviewed Genetics PLoS medicine

    Key finding: Although altered lipid metabolism has been extensively implicated in the pathogenesis of Alzheimer disease (AD) through cell biological, epidemiological, and genetic studies, the molecular mechanisms linking cholesterol and AD pathology are still not well understood and contradictory results have been reported. +2 more findings

  3. 2014-09-13

    [Hearing impairment and dementia]

    ✓ Peer-reviewed Risk factors Zeitschrift fur Gerontologie und Geriatrie

    Key finding: The prevalence of dementia and hearing problems increases in aging societies. +4 more findings

  4. 2014-09-13

    Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis

    ✓ Peer-reviewed How common it is Acta psychiatrica Scandinavica

    Key finding: Older people with SMC but no objective complaints are twice as likely to develop dementia as individuals without SMC. +2 more findings

  5. 2014-09-12

    Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients

    ✓ Peer-reviewed Treatments Nature communications

    Key finding: Our results suggest that aside from filamentous aggregates, TDP-43 oligomers may play a role in TDP-43 pathogenesis.

  6. 2014-09-12

    Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer's disease and related dementia living in long-term care facilities

    ✓ Peer-reviewed Clinical safety Clinical interventions in aging

    Key finding: A lighting intervention, tailored to increase daytime circadian stimulation, can be used to increase sleep quality and improve behavior in patients with ADRD. +2 more findings

  7. 2014-09-12

    The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies

    ✓ Peer-reviewed Clinical safety Brain pathology (Zurich, Switzerland)

    Key finding: These findings can contribute to a large variety of less well-explained PD and DLB symptoms (eg, gait and postural instability, impaired balance and postural reflexes, falls, ingestive and oculomotor dysfunctions) and point to the occurrence of disturbances of intra-axonal transport processes and transneuronal spread of the underlying pathological processes of PD and DLB along anatomical pathways.

  8. 2014-09-12

    Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo

    ✓ Peer-reviewed Genetics The Journal of biological chemistry

    Key finding: RXR agonists induced no beneficial effects in the E4FAD-HP in a prevention protocol (5-6 months) and actually increased soluble Aβ levels in E3FAD-CX and E4FAD-CX with the short-term protocol, possibly the result of systemic hepatomegaly. +1 more finding

  9. 2014-09-11

    The Mini-Addenbrooke's Cognitive Examination: a new assessment tool for dementia

    ✓ Peer-reviewed Cognitive tests and assessment Dementia and geriatric cognitive disorders

    Key finding: We developed and validated the Mini-Addenbrooke's Cognitive Examination (M-ACE) in dementia patients. +3 more findings

  10. 2014-09-10

    APOE ε4: the most prevalent yet understudied risk factor for Alzheimer's disease

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Although this approach still remains valid, none of the compounds tested to date have produced clinically meaningful results.

  11. 2014-09-10

    Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review

    ✓ Peer-reviewed Vascular contributions NeuroImage. Clinical

    Key finding: In conclusion, DCE-MRI is shown to provide valuable information in a large variety of applications, ranging from common applications, such as grading of primary brain tumors, to more recent applications, such as assessment of subtle BBB dysfunction in Alzheimer's disease.

  12. 2014-09-10

    Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

    ✓ Peer-reviewed Long-term cohort studies Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plasma amyloid-β (Aβ) peptide levels have been examined as a low-cost accessible marker for risk of incident Alzheimer's disease (AD) and dementia, but results have varied between studies. +3 more findings

  13. 2014-09-09

    Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment

    ✓ Peer-reviewed Vascular contributions Neuropsychiatric disease and treatment

    Key finding: Cognitive impairment and memory dysfunction following stroke diagnosis are common symptoms that significantly affect the survivors' quality of life. +1 more finding

  14. 2014-09-09

    Benzodiazepine use and risk of Alzheimer's disease: case-control study

    ✓ Peer-reviewed Getting a diagnosis BMJ (Clinical research ed.)

    Key finding: Benzodiazepine use is associated with an increased risk of Alzheimer's disease. +2 more findings

  15. 2014-09-08

    Common genetic variants associated with cognitive performance identified using the proxy-phenotype method

    ✓ Peer-reviewed Genetics Proceedings of the National Academy of Sciences of the United States of America

    Key finding: We identify common genetic variants associated with cognitive performance using a two-stage approach, which we call the proxy-phenotype method. +3 more findings

  16. 2014-09-08

    A stereological study of the mediodorsal thalamic nucleus in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuroscience

    Key finding: The total number of neurons and glial cells in the mediodorsal thalamic (MDT) nucleus of four aged females with Down syndrome (DS; mean age 69years) was estimated and compared to six age- and sex-matched controls. +2 more findings

  17. 2014-09-07

    Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy

    ✓ Peer-reviewed Treatments Acta neuropathologica

    Key finding: Aβ immunotherapy for Alzheimer's disease (AD) results in the removal of Aβ plaques and increased cerebral amyloid angiopathy (CAA). +4 more findings

  18. 2014-09-06

    Measuring end-of-life care and outcomes in residential care/assisted living and nursing homes

    ✓ Peer-reviewed Health systems and care delivery Journal of pain and symptom management

    Key finding: Prioritizing measures that distinguish the assessment of care from the assessment of dying, and secondarily that exhibit an acceptable factor structure, this study recommends two measures of care-the Family Perceptions of Physician-Family Caregiver Communication and the End of Life in Dementia (EOLD)-Satisfaction With Care-and two measures of outcomes-the EOLD-Symptom Management and the EOLD-Comfort Assessment in Dying. +4 more findings

  19. 2014-09-06

    Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models

    ✓ Peer-reviewed TREM2 and immune genetics Neurobiology of aging

    Key finding: These subjects were grouped based on neurofibrillary pathology into 3 groups: Braak stages 0-II, Braak stages III-IV, and Braak stages V-VI. +3 more findings

  20. 2014-09-04

    Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

    ✓ Peer-reviewed Hippocampus size on brain scans The Lancet. Neurology

    Key finding: As preclinical Alzheimer's disease becomes a target for therapeutic intervention, the overlap between imaging abnormalities associated with typical ageing and those associated with Alzheimer's disease needs to be recognised. +3 more findings

  21. 2014-09-04
  22. 2014-09-04

    Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias

    ✓ Peer-reviewed Lewy body dementia PLoS genetics

    Key finding: GalNAc transferase 7 (GALNT7), ATP-Binding Cassette, Sub-Family G (WHITE), Member 1 (ABCG1), and an intergenic region on chromosome 9 were associated with NP score; and Potassium Large Conductance Calcium-Activated Channel, Subfamily M, Beta Member 2 (KCNMB2) was strongly associated with HS. +1 more finding

  23. 2014-09-03

    Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults

    ✓ Peer-reviewed Hippocampus size on brain scans Neurology

    Key finding: We found that longitudinal measures of cortical atrophy were widely correlated with sleep quality. +4 more findings

  24. 2014-09-03

    End of life care: The experiences of advance care planning amongst family caregivers of people with advanced dementia - A qualitative study

    ✓ Peer-reviewed End-of-life care Dementia (London, England)

    Key finding: Advance care planning can be facilitated with the family caregiver in the context of everyday practice within the nursing home environment for older people with dementia.

  25. 2014-09-03

    An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex

    ✓ Peer-reviewed Laboratory science Journal of Neuroscience

    The major cell classes of the brain differ in their developmental processes, metabolism, signaling, and function.

Browse the library by subject, with the full score breakdown →